Loading…

Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor

Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 1998-05, Vol.95 (11), p.6061-6066
Main Authors: Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.), Farruggella, T.J, Symes, A, Karow, M.L, Yancopoulos, G.D, Stahl, N
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243
cites cdi_FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243
container_end_page 6066
container_issue 11
container_start_page 6061
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 95
creator Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.)
Farruggella, T.J
Symes, A
Karow, M.L
Yancopoulos, G.D
Stahl, N
description Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR response. Evidence suggests that transcriptional activation of target genes by STAT3 (signal transducer and activator of transcription) in the hypothalamus is a critical pathway that mediates leptin's action. Herein we report that activation of ObR induces the tyrosine phosphorylation of the tyrosine phosphatase SH2-containing phosphatase 2 (SHP-2) and demonstrate that Tyr986 within the ObR cytoplasmic domain is essential to mediate phosphorylation of SHP-2 and binding of SHP-2 to ObR. Surprisingly, mutation of Tyr986 to Phe, which abrogates SHP-2 phosphorylatlon and binding to the receptor, dramatically increases gene induction mediated by STAT3. Our findings indicate that SHP-2 is a negative regulator of STAT3-mediated gene induction after activation of ObR and raise the possibility that blocking the interaction of SHP-2 with ObR could overcome leptin resistance by boosting leptin's weight-reducing effects in obese individuals
doi_str_mv 10.1073/pnas.95.11.6061
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_16355727</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>45331</jstor_id><sourcerecordid>45331</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243</originalsourceid><addsrcrecordid>eNqFkcFrFDEUxgdRaq2eBUEZPOhptu9lJpMJeJFSrVDoofYcspk3u1lmkzHJVvvfm2GXpXrQUxK-3_fxXr6ieI2wQBD1-eR0XEi-QFy00OKT4hRBYtU2Ep4WpwBMVF3DmufFixg3ACB5ByfFiWzzFcVpoS_dWjtj3aocaUrWlYHi5F2kcvlQToHuyaVZvb1ilfEuaevm57T2cVrrpDPISusSBW2S9a78adO6vFnmHJMDfXhZPBv0GOnV4Twr7r5cfr-4qq5vvn67-HxdGd5AqrDDBpC4bqkzIEUtBXEAanu27JeG9WKQvcnLGdELol52QgN1PQ68R2JNfVZ82udOu-WWepPnDnpUU7BbHR6U11b9qTi7Vit_r5jgHc_2Dwd78D92FJPa2mhoHLUjv4tKyE4CCPFfENuac8Fm8P1f4Mbvgst_oBhg3eUwzND5HjLBxxhoOA6MoOaG1dywklwhqrnh7Hj7eM8jf6g06x8P-mw8qscANezGMdGvlMl3_yQz8GYPbGIu8kg0vK4fzTFor_Qq2KjublFKAbJm2NW_Ae_1zYY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201380771</pqid></control><display><type>article</type><title>Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>PubMed Central</source><creator>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.) ; Farruggella, T.J ; Symes, A ; Karow, M.L ; Yancopoulos, G.D ; Stahl, N</creator><creatorcontrib>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.) ; Farruggella, T.J ; Symes, A ; Karow, M.L ; Yancopoulos, G.D ; Stahl, N</creatorcontrib><description>Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR response. Evidence suggests that transcriptional activation of target genes by STAT3 (signal transducer and activator of transcription) in the hypothalamus is a critical pathway that mediates leptin's action. Herein we report that activation of ObR induces the tyrosine phosphorylation of the tyrosine phosphatase SH2-containing phosphatase 2 (SHP-2) and demonstrate that Tyr986 within the ObR cytoplasmic domain is essential to mediate phosphorylation of SHP-2 and binding of SHP-2 to ObR. Surprisingly, mutation of Tyr986 to Phe, which abrogates SHP-2 phosphorylatlon and binding to the receptor, dramatically increases gene induction mediated by STAT3. Our findings indicate that SHP-2 is a negative regulator of STAT3-mediated gene induction after activation of ObR and raise the possibility that blocking the interaction of SHP-2 with ObR could overcome leptin resistance by boosting leptin's weight-reducing effects in obese individuals</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.95.11.6061</identifier><identifier>PMID: 9600917</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>ADN RECOMBINADO ; ADN RECOMBINE ; Animals ; Antibodies ; BINDING ; Biochemistry ; Biological Sciences ; Carrier Proteins - genetics ; Carrier Proteins - metabolism ; COS Cells ; Cytokines ; DNA-Binding Proteins - metabolism ; ESTERASAS ; ESTERASE ; ESTERASES ; EXPRESION GENICA ; EXPRESSION DES GENES ; FACTEUR DE TRANSCRIPTION ; FACTORES DE TRANSCRIPCION ; FOSFORILACION ; GENE ; GENE EXPRESSION ; Gene induction ; GENES ; GENETIC REGULATION ; GENETICA ; GENETICS ; GENETIQUE ; HORMONAS ; HORMONE ; HORMONE RECEPTORS ; HORMONES ; Humans ; INHIBICION ; INHIBITION ; Intracellular Signaling Peptides and Proteins ; Leptin ; LUCIFERASE ; MICE ; Mutation ; Neurons ; Obesity ; Obesity - metabolism ; OXIDOREDUCTASES ; OXIDORREDUCTASAS ; OXYDOREDUCTASE ; PEPTIDE ; PEPTIDES ; PEPTIDOS ; Phosphatases ; PHOSPHOPROTEIN PHOSPHATASE ; PHOSPHORYLATION ; POLYPEPTIDES ; PROMOTERS ; Protein Phosphatase 2 ; Protein Tyrosine Phosphatase, Non-Receptor Type 11 ; Protein Tyrosine Phosphatase, Non-Receptor Type 6 ; Protein Tyrosine Phosphatases - metabolism ; Proteins ; Proteins - metabolism ; RATON ; RECEPTEUR D'HORMONE ; RECEPTORES DE HORMONAS ; Receptors ; Receptors, Cell Surface ; Receptors, Cytokine - genetics ; Receptors, Cytokine - metabolism ; Receptors, Leptin ; RECOMBINANT DNA ; REPORTER GENES ; SH2 Domain-Containing Protein Tyrosine Phosphatases ; Signal Transduction ; SOURIS ; src Homology Domains ; STAT3 Transcription Factor ; TIROSINA ; Trans-Activators - metabolism ; TRANSCRIPCION ; TRANSCRIPTION ; TRANSCRIPTION FACTORS ; Transfection ; TYROSINE</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1998-05, Vol.95 (11), p.6061-6066</ispartof><rights>Copyright 1993-1998 National Academy of Sciences</rights><rights>Copyright National Academy of Sciences May 26, 1998</rights><rights>Copyright © 1998, The National Academy of Sciences 1998</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243</citedby><cites>FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/95/11.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/45331$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/45331$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9600917$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.)</creatorcontrib><creatorcontrib>Farruggella, T.J</creatorcontrib><creatorcontrib>Symes, A</creatorcontrib><creatorcontrib>Karow, M.L</creatorcontrib><creatorcontrib>Yancopoulos, G.D</creatorcontrib><creatorcontrib>Stahl, N</creatorcontrib><title>Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR response. Evidence suggests that transcriptional activation of target genes by STAT3 (signal transducer and activator of transcription) in the hypothalamus is a critical pathway that mediates leptin's action. Herein we report that activation of ObR induces the tyrosine phosphorylation of the tyrosine phosphatase SH2-containing phosphatase 2 (SHP-2) and demonstrate that Tyr986 within the ObR cytoplasmic domain is essential to mediate phosphorylation of SHP-2 and binding of SHP-2 to ObR. Surprisingly, mutation of Tyr986 to Phe, which abrogates SHP-2 phosphorylatlon and binding to the receptor, dramatically increases gene induction mediated by STAT3. Our findings indicate that SHP-2 is a negative regulator of STAT3-mediated gene induction after activation of ObR and raise the possibility that blocking the interaction of SHP-2 with ObR could overcome leptin resistance by boosting leptin's weight-reducing effects in obese individuals</description><subject>ADN RECOMBINADO</subject><subject>ADN RECOMBINE</subject><subject>Animals</subject><subject>Antibodies</subject><subject>BINDING</subject><subject>Biochemistry</subject><subject>Biological Sciences</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - metabolism</subject><subject>COS Cells</subject><subject>Cytokines</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>ESTERASAS</subject><subject>ESTERASE</subject><subject>ESTERASES</subject><subject>EXPRESION GENICA</subject><subject>EXPRESSION DES GENES</subject><subject>FACTEUR DE TRANSCRIPTION</subject><subject>FACTORES DE TRANSCRIPCION</subject><subject>FOSFORILACION</subject><subject>GENE</subject><subject>GENE EXPRESSION</subject><subject>Gene induction</subject><subject>GENES</subject><subject>GENETIC REGULATION</subject><subject>GENETICA</subject><subject>GENETICS</subject><subject>GENETIQUE</subject><subject>HORMONAS</subject><subject>HORMONE</subject><subject>HORMONE RECEPTORS</subject><subject>HORMONES</subject><subject>Humans</subject><subject>INHIBICION</subject><subject>INHIBITION</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>Leptin</subject><subject>LUCIFERASE</subject><subject>MICE</subject><subject>Mutation</subject><subject>Neurons</subject><subject>Obesity</subject><subject>Obesity - metabolism</subject><subject>OXIDOREDUCTASES</subject><subject>OXIDORREDUCTASAS</subject><subject>OXYDOREDUCTASE</subject><subject>PEPTIDE</subject><subject>PEPTIDES</subject><subject>PEPTIDOS</subject><subject>Phosphatases</subject><subject>PHOSPHOPROTEIN PHOSPHATASE</subject><subject>PHOSPHORYLATION</subject><subject>POLYPEPTIDES</subject><subject>PROMOTERS</subject><subject>Protein Phosphatase 2</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 11</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 6</subject><subject>Protein Tyrosine Phosphatases - metabolism</subject><subject>Proteins</subject><subject>Proteins - metabolism</subject><subject>RATON</subject><subject>RECEPTEUR D'HORMONE</subject><subject>RECEPTORES DE HORMONAS</subject><subject>Receptors</subject><subject>Receptors, Cell Surface</subject><subject>Receptors, Cytokine - genetics</subject><subject>Receptors, Cytokine - metabolism</subject><subject>Receptors, Leptin</subject><subject>RECOMBINANT DNA</subject><subject>REPORTER GENES</subject><subject>SH2 Domain-Containing Protein Tyrosine Phosphatases</subject><subject>Signal Transduction</subject><subject>SOURIS</subject><subject>src Homology Domains</subject><subject>STAT3 Transcription Factor</subject><subject>TIROSINA</subject><subject>Trans-Activators - metabolism</subject><subject>TRANSCRIPCION</subject><subject>TRANSCRIPTION</subject><subject>TRANSCRIPTION FACTORS</subject><subject>Transfection</subject><subject>TYROSINE</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkcFrFDEUxgdRaq2eBUEZPOhptu9lJpMJeJFSrVDoofYcspk3u1lmkzHJVvvfm2GXpXrQUxK-3_fxXr6ieI2wQBD1-eR0XEi-QFy00OKT4hRBYtU2Ep4WpwBMVF3DmufFixg3ACB5ByfFiWzzFcVpoS_dWjtj3aocaUrWlYHi5F2kcvlQToHuyaVZvb1ilfEuaevm57T2cVrrpDPISusSBW2S9a78adO6vFnmHJMDfXhZPBv0GOnV4Twr7r5cfr-4qq5vvn67-HxdGd5AqrDDBpC4bqkzIEUtBXEAanu27JeG9WKQvcnLGdELol52QgN1PQ68R2JNfVZ82udOu-WWepPnDnpUU7BbHR6U11b9qTi7Vit_r5jgHc_2Dwd78D92FJPa2mhoHLUjv4tKyE4CCPFfENuac8Fm8P1f4Mbvgst_oBhg3eUwzND5HjLBxxhoOA6MoOaG1dywklwhqrnh7Hj7eM8jf6g06x8P-mw8qscANezGMdGvlMl3_yQz8GYPbGIu8kg0vK4fzTFor_Qq2KjublFKAbJm2NW_Ae_1zYY</recordid><startdate>19980526</startdate><enddate>19980526</enddate><creator>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.)</creator><creator>Farruggella, T.J</creator><creator>Symes, A</creator><creator>Karow, M.L</creator><creator>Yancopoulos, G.D</creator><creator>Stahl, N</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><general>National Academy of Sciences</general><general>The National Academy of Sciences</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19980526</creationdate><title>Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor</title><author>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.) ; Farruggella, T.J ; Symes, A ; Karow, M.L ; Yancopoulos, G.D ; Stahl, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>ADN RECOMBINADO</topic><topic>ADN RECOMBINE</topic><topic>Animals</topic><topic>Antibodies</topic><topic>BINDING</topic><topic>Biochemistry</topic><topic>Biological Sciences</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - metabolism</topic><topic>COS Cells</topic><topic>Cytokines</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>ESTERASAS</topic><topic>ESTERASE</topic><topic>ESTERASES</topic><topic>EXPRESION GENICA</topic><topic>EXPRESSION DES GENES</topic><topic>FACTEUR DE TRANSCRIPTION</topic><topic>FACTORES DE TRANSCRIPCION</topic><topic>FOSFORILACION</topic><topic>GENE</topic><topic>GENE EXPRESSION</topic><topic>Gene induction</topic><topic>GENES</topic><topic>GENETIC REGULATION</topic><topic>GENETICA</topic><topic>GENETICS</topic><topic>GENETIQUE</topic><topic>HORMONAS</topic><topic>HORMONE</topic><topic>HORMONE RECEPTORS</topic><topic>HORMONES</topic><topic>Humans</topic><topic>INHIBICION</topic><topic>INHIBITION</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>Leptin</topic><topic>LUCIFERASE</topic><topic>MICE</topic><topic>Mutation</topic><topic>Neurons</topic><topic>Obesity</topic><topic>Obesity - metabolism</topic><topic>OXIDOREDUCTASES</topic><topic>OXIDORREDUCTASAS</topic><topic>OXYDOREDUCTASE</topic><topic>PEPTIDE</topic><topic>PEPTIDES</topic><topic>PEPTIDOS</topic><topic>Phosphatases</topic><topic>PHOSPHOPROTEIN PHOSPHATASE</topic><topic>PHOSPHORYLATION</topic><topic>POLYPEPTIDES</topic><topic>PROMOTERS</topic><topic>Protein Phosphatase 2</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 11</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 6</topic><topic>Protein Tyrosine Phosphatases - metabolism</topic><topic>Proteins</topic><topic>Proteins - metabolism</topic><topic>RATON</topic><topic>RECEPTEUR D'HORMONE</topic><topic>RECEPTORES DE HORMONAS</topic><topic>Receptors</topic><topic>Receptors, Cell Surface</topic><topic>Receptors, Cytokine - genetics</topic><topic>Receptors, Cytokine - metabolism</topic><topic>Receptors, Leptin</topic><topic>RECOMBINANT DNA</topic><topic>REPORTER GENES</topic><topic>SH2 Domain-Containing Protein Tyrosine Phosphatases</topic><topic>Signal Transduction</topic><topic>SOURIS</topic><topic>src Homology Domains</topic><topic>STAT3 Transcription Factor</topic><topic>TIROSINA</topic><topic>Trans-Activators - metabolism</topic><topic>TRANSCRIPCION</topic><topic>TRANSCRIPTION</topic><topic>TRANSCRIPTION FACTORS</topic><topic>Transfection</topic><topic>TYROSINE</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.)</creatorcontrib><creatorcontrib>Farruggella, T.J</creatorcontrib><creatorcontrib>Symes, A</creatorcontrib><creatorcontrib>Karow, M.L</creatorcontrib><creatorcontrib>Yancopoulos, G.D</creatorcontrib><creatorcontrib>Stahl, N</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carpenter, L.R. (Regeneron Pharmaceuticals, Inc., Tarrytown, NY.)</au><au>Farruggella, T.J</au><au>Symes, A</au><au>Karow, M.L</au><au>Yancopoulos, G.D</au><au>Stahl, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1998-05-26</date><risdate>1998</risdate><volume>95</volume><issue>11</issue><spage>6061</spage><epage>6066</epage><pages>6061-6066</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR response. Evidence suggests that transcriptional activation of target genes by STAT3 (signal transducer and activator of transcription) in the hypothalamus is a critical pathway that mediates leptin's action. Herein we report that activation of ObR induces the tyrosine phosphorylation of the tyrosine phosphatase SH2-containing phosphatase 2 (SHP-2) and demonstrate that Tyr986 within the ObR cytoplasmic domain is essential to mediate phosphorylation of SHP-2 and binding of SHP-2 to ObR. Surprisingly, mutation of Tyr986 to Phe, which abrogates SHP-2 phosphorylatlon and binding to the receptor, dramatically increases gene induction mediated by STAT3. Our findings indicate that SHP-2 is a negative regulator of STAT3-mediated gene induction after activation of ObR and raise the possibility that blocking the interaction of SHP-2 with ObR could overcome leptin resistance by boosting leptin's weight-reducing effects in obese individuals</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>9600917</pmid><doi>10.1073/pnas.95.11.6061</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 1998-05, Vol.95 (11), p.6061-6066
issn 0027-8424
1091-6490
language eng
recordid cdi_proquest_miscellaneous_16355727
source JSTOR Archival Journals and Primary Sources Collection; PubMed Central
subjects ADN RECOMBINADO
ADN RECOMBINE
Animals
Antibodies
BINDING
Biochemistry
Biological Sciences
Carrier Proteins - genetics
Carrier Proteins - metabolism
COS Cells
Cytokines
DNA-Binding Proteins - metabolism
ESTERASAS
ESTERASE
ESTERASES
EXPRESION GENICA
EXPRESSION DES GENES
FACTEUR DE TRANSCRIPTION
FACTORES DE TRANSCRIPCION
FOSFORILACION
GENE
GENE EXPRESSION
Gene induction
GENES
GENETIC REGULATION
GENETICA
GENETICS
GENETIQUE
HORMONAS
HORMONE
HORMONE RECEPTORS
HORMONES
Humans
INHIBICION
INHIBITION
Intracellular Signaling Peptides and Proteins
Leptin
LUCIFERASE
MICE
Mutation
Neurons
Obesity
Obesity - metabolism
OXIDOREDUCTASES
OXIDORREDUCTASAS
OXYDOREDUCTASE
PEPTIDE
PEPTIDES
PEPTIDOS
Phosphatases
PHOSPHOPROTEIN PHOSPHATASE
PHOSPHORYLATION
POLYPEPTIDES
PROMOTERS
Protein Phosphatase 2
Protein Tyrosine Phosphatase, Non-Receptor Type 11
Protein Tyrosine Phosphatase, Non-Receptor Type 6
Protein Tyrosine Phosphatases - metabolism
Proteins
Proteins - metabolism
RATON
RECEPTEUR D'HORMONE
RECEPTORES DE HORMONAS
Receptors
Receptors, Cell Surface
Receptors, Cytokine - genetics
Receptors, Cytokine - metabolism
Receptors, Leptin
RECOMBINANT DNA
REPORTER GENES
SH2 Domain-Containing Protein Tyrosine Phosphatases
Signal Transduction
SOURIS
src Homology Domains
STAT3 Transcription Factor
TIROSINA
Trans-Activators - metabolism
TRANSCRIPCION
TRANSCRIPTION
TRANSCRIPTION FACTORS
Transfection
TYROSINE
title Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A23%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancing%20leptin%20response%20by%20preventing%20SH2-containing%20phosphatase%202%20interaction%20with%20Ob%20receptor&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Carpenter,%20L.R.%20(Regeneron%20Pharmaceuticals,%20Inc.,%20Tarrytown,%20NY.)&rft.date=1998-05-26&rft.volume=95&rft.issue=11&rft.spage=6061&rft.epage=6066&rft.pages=6061-6066&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.95.11.6061&rft_dat=%3Cjstor_proqu%3E45331%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-181401e5a6e8c097397e500e6d2bdbc2d7f9dc109c7d7eed987a0e8d1f5d1e243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=201380771&rft_id=info:pmid/9600917&rft_jstor_id=45331&rfr_iscdi=true